Al Reaves
Gründer bei Ophthaconsult LLC
Profil
Al Reaves is the founder of Ophthaconsult LLC, which was founded in 2010.
He holds the title of President at Ophthaconsult LLC.
Dr. Reaves also held former positions at Healios KK, Othera Pharmaceuticals, Inc., Alcon Laboratories, Inc., Xenon Vision, Inc., Neurotech Pharmaceuticals, Inc. (United States), Acucela, Inc., and Novartis Ophthalmics, Inc. At Healios KK, he held the title of Director & Manager-Overseas Development from 2016 to 2018.
At Othera Pharmaceuticals, Inc., he held the title of Senior Vice President-Clinical Development.
At Alcon Laboratories, Inc., Xenon Vision, Inc., Neurotech Pharmaceuticals, Inc. (United States), and Novartis Ophthalmics, Inc., he held the title of Principal.
Dr. Reaves received a doctorate degree from the University of Illinois.
Aktive Positionen von Al Reaves
| Unternehmen | Position | Beginn |
|---|---|---|
| Ophthaconsult LLC | Gründer | 19.01.2010 |
Ehemalige bekannte Positionen von Al Reaves
| Unternehmen | Position | Ende |
|---|---|---|
| ACUCELA INC | Corporate Officer/Principal | - |
| HEALIOS K.K. | Direktor/Vorstandsmitglied | 01.03.2018 |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Corporate Officer/Principal | - |
Novartis Ophthalmics, Inc.
 Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Corporate Officer/Principal | - |
Xenon Vision, Inc.
 Xenon Vision, Inc. Miscellaneous Commercial ServicesCommercial Services Part of W World Corp., Xenon Vision, Inc. is a vision research concern. The company is based in Alachua, FL. Xenon Vision was acquired by Pharmatec, Inc. on November 03, 1992. | Corporate Officer/Principal | - |
Ausbildung von Al Reaves
| University of Illinois | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HEALIOS K.K. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Othera Pharmaceuticals, Inc.
 Othera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2002, Othera Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing treatments for ophthalmic diseases. Othera is also engaged in the discovery of a novel set of orally available compounds to address severe medical conditions including inflammatory and oncology-related diseases. | Health Technology |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Health Technology |
Xenon Vision, Inc.
Xenon Vision, Inc. Miscellaneous Commercial ServicesCommercial Services Part of W World Corp., Xenon Vision, Inc. is a vision research concern. The company is based in Alachua, FL. Xenon Vision was acquired by Pharmatec, Inc. on November 03, 1992. | Commercial Services |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Health Technology |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Health Technology |
| Ophthaconsult LLC |
